| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88122890 | FILING DATE | 09/19/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | PATEL, SAMIR RAMESH |
L.O. ASSIGNED | 106 |
PUB INFORMATION |
|||
| RUN DATE | 10/09/2020 | ||
| PUB DATE | 02/26/2019 | ||
| STATUS | 732-THIRD EXTENSION - GRANTED | ||
| STATUS DATE | 10/07/2020 | ||
| LITERAL MARK ELEMENT | GPCR THERAPEUTICS | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | GPCR THERAPEUTICS |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | GPCR Therapeutics, Inc. |
| ADDRESS | Room 407, Nakseongdae R&D Center 38, Nakseongdae-ro, Gwanak-gu Seoul, 08790 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Republic of Korea |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Medical diagnostic apparatus for detecting cancer |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Biological, medical, and scientific research in the field of cancer research, diagnosis, and treatment; Scientific research and development in the biological, medical, health care, or pharmacological fields; Clinical and pharmacological research and testing services performed in conjunction with clinical trials; Scientific research and development services in the fields of biotechnology, new drug development, pharmacological formulation, and microbiological research; Scientific research consultation and information services in the biological, medical, health care, or pharmacological fields; Information technology management consultation and new product development services in the biological, medical, health care, or pharmacological fields |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Clinical and medical testing for medical diagnostic purposes; Medical testing for diagnostic purposes of reagents, clinical and non-clinical samples, nucleic acids, proteins, and pharmacological formulations |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "GPCR" AND "THERAPEUTICS" |
| DESCRIPTION OF MARK | The mark consists of the uppercase letters "GP" on top of the uppercase letters "CR" next to the word "therapeutics" in lowercase letters, all of which appear on top of a repeating pattern of generally horizontal lines that each begin on the left with a concave curved portion, followed by a combination of angled, straight, and zig zag portions, and ending with another straight portion. The lines are oriented on top of each other and do not intersect, and portions of the top and bottom lines are cut off to give the mark a generally rectangular appearance. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/09/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 033 |
| 10/07/2020 | EX3G | S | EXTENSION 3 GRANTED | 032 |
| 10/07/2020 | EXT3 | S | EXTENSION 3 FILED | 031 |
| 10/07/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 030 |
| 04/03/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 029 |
| 04/01/2020 | EX2G | S | EXTENSION 2 GRANTED | 028 |
| 04/01/2020 | EXT2 | S | EXTENSION 2 FILED | 027 |
| 04/01/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 026 |
| 10/08/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 025 |
| 10/04/2019 | EX1G | S | EXTENSION 1 GRANTED | 024 |
| 10/04/2019 | EXT1 | S | EXTENSION 1 FILED | 023 |
| 10/04/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 022 |
| 05/08/2019 | NOAC | E | CORRECTED NOA E-MAILED | 021 |
| 05/07/2019 | ICNA | I | NOTICE OF ALLOWANCE CORRECTION ENTERED | 020 |
| 05/07/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 019 |
| 04/24/2019 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | 018 |
| 04/23/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 017 |
| 02/26/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 016 |
| 02/26/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 015 |
| 02/06/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 014 |
| 01/17/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 013 |
| 01/17/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 01/17/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 01/16/2019 | ALIE | A | ASSIGNED TO LIE | 010 |
| 01/10/2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 009 |
| 01/10/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
| 01/03/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 01/03/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 01/03/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 01/01/2019 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 09/26/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 09/25/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 09/22/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Tracy A. Stitt |
| CORRESPONDENCE ADDRESS | Tracy A. Stitt JONES DAY 250 VESEY STREET NEW YORK NY 10281-1047 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | GPCR Therapeutics Inc. |
| ADDRESS | Room 407, Nakseongdae R&D Center 38, Nakseongdae-ro, Gwanak-gu Seoul, 08790 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Republic of Korea |